Monopar to Present at Roth Inaugural Healthcare Opportunities Conference

Rhea-AI Summary

Monopar Therapeutics (Nasdaq: MNPR), a clinical-stage biopharmaceutical company, announced its CEO, Chandler Robinson, will present at the Roth Inaugural Healthcare Opportunities Conference on October 6, 2022, at 12:00 p.m. (ET). The conference will be held at The Yale Club, New York City.

Monopar focuses on developing therapeutics aimed at improving the quality of life for cancer patients, with a pipeline that includes Validive® and camsirubicin for different cancer treatments. For more information, visit www.monopartx.com.

WILMETTE, Ill., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference.

Presentation Details:

Date: October 6, 2022
Time: 12:00 p.m. (ET)
Location: The Yale Club, New York City, New York

https://www.roth.com/conferences/upcoming-conferences

About Monopar Therapeutics Inc.

Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar's pipeline consists of Validive^® for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced soft tissue sarcoma; a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19; and an early-stage camsirubicin analog, MNPR-202, for various cancers. For more information, visit: www.monopartx.com.

CONTACT:  

Monopar Therapeutics Inc.
Investor Relations  
Kim R. Tsuchimoto  
Chief Financial Officer  
kimtsu@monopartx.com

Follow Monopar on social media for updates: 
Twitter: @MonoparTx  LinkedIn: Monopar Therapeutics

 

FAQ

What is the date of the Monopar Therapeutics presentation at the Roth Conference?

The presentation by Monopar Therapeutics will take place on October 6, 2022.

Who will represent Monopar Therapeutics at the Roth Inaugural Healthcare Opportunities Conference?

Chandler Robinson, the CEO of Monopar Therapeutics, will represent the company.

Where is the Roth Inaugural Healthcare Opportunities Conference being held?

The conference will be held at The Yale Club in New York City.

What time is Monopar Therapeutics' presentation scheduled for?

Monopar Therapeutics' presentation is scheduled for 12:00 p.m. (ET).

What is the focus of Monopar Therapeutics' research?

Monopar Therapeutics focuses on developing therapeutics to improve the quality of life for cancer patients.